GEMINA LABS LTD

Share · CA3686501071 · A3CWW7 (XCNQ)

No Price

19.03.2026 20:00

Current Prices from GEMINA LABS LTD

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	GLABF	USD	19.03.2026 20:00	0,05 USD	0,00 USD
Frankfurt	8I7.F	EUR	27.02.2026 14:25	0,02 EUR	-

Share Float & Liquidity

Free Float 57,03 %

Shares Float 43,67 M

Shares Outstanding 76,57 M

Company Profile for GEMINA LABS LTD Share

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.

AI Analysis of GEMINA LABS LTD

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of GEMINA LABS LTD

No AI threads available for this company yet.

Company Data

Name GEMINA LABS LTD

Company Gemina Laboratories Ltd.

Website https://www.geminalabs.com

Primary Exchange

Frankfurt

WKN A3CWW7

ISIN CA3686501071

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Brian Firth

Country Canada

Currency EUR

Employees 0,0 T

Address 3800 Westbrook Mall, V6S 2L9 Burnaby

IPO Date 2021-08-12

Ticker Symbols

Name	Symbol
Over The Counter	GLABF
CSE LISTED	GLAB.CN
Frankfurt	8I7.F

More Shares

Investors who hold GEMINA LABS LTD also have the following shares in their portfolio:

DCW Limited Share

TOYOTA MOTOR FINANCE (NETHERLANDS) B.V. FLTG RTE NTS 04/11/22 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog